Luethi, Dino

Designer drugs: mechanism of action and adverse effects

Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology

Forensic Toxicology and Drug AnalysisPoisoning and overdose treatments

Cited by 262

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

Ley, L., Holze, F., Arikci, D., Becker, A. M., Straumann, I., Klaiber, A., Coviello, F., Dierbach, S., Thomann, J., Duthaler, U., et al. (2023) · Neuropsychopharmacology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 130

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

Vogt, S. B., Ley, L., Erne, L., Straumann, I., Becker, A. M., Klaiber, A., Holze, F., Vandersmissen, A., Mueller, L., Duthaler, U., et al. (2023) · Translational Psychiatry

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 89

Structural basis of organic cation transporter-3 inhibition

Khanppnavar, B., Maier, J., Herborg, F., Gradisch, R., Lazzarin, E., Luethi, D., Yang, J.-W., Qi, C., Holy, M., Jäntsch, K., et al. (2022) · Nature Communications

Drug Transport and Resistance MechanismsPharmacogenetics and Drug Metabolism

Cited by 77

Structural basis of organic cation transporter-3 inhibition

Khanppnavar, B., Maier, J., Herborg, F., Gradisch, R., Lazzarin, E., Luethi, D., Yang, J.-W., Qi, C., Holy, M., Jäntsch, K., et al. (2022) · Nature Communications

Drug Transport and Resistance MechanismsPharmacogenetics and Drug Metabolism

Cited by 77